Literature DB >> 24294966

T regulatory cells in childhood arthritis--novel insights.

Anne M Pesenacker1, Lucy R Wedderburn.   

Abstract

In recent years, there have been many new developments in the field of regulatory T cells (Treg), challenging the consensus on their behaviour, classification and role(s) in disease. The role Treg might play in autoimmune disease appears to be more complex than previously thought. Here, we discuss the current knowledge of regulatory T cells through animal and human research and illustrate the recent developments in childhood autoimmune arthritis (juvenile idiopathic arthritis (JIA)). Furthermore, this review summarises our understanding of the fields and assesses current and future implications for Treg in the treatment of JIA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24294966     DOI: 10.1017/erm.2013.14

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  9 in total

1.  T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression.

Authors:  Scott J Patterson; Anne M Pesenacker; Adele Y Wang; Jana Gillies; Majid Mojibian; Kim Morishita; Rusung Tan; Timothy J Kieffer; C Bruce Verchere; Constadina Panagiotopoulos; Megan K Levings
Journal:  J Clin Invest       Date:  2016-02-08       Impact factor: 14.808

Review 2.  Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells.

Authors:  Pushpa Pandiyan; Jinfang Zhu
Journal:  Cytokine       Date:  2015-07-10       Impact factor: 3.861

3.  Broadening our understanding of the genetics of Juvenile Idiopathic Arthritis (JIA): Interrogation of three dimensional chromatin structures and genetic regulatory elements within JIA-associated risk loci.

Authors:  Kaiyu Jiang; Haeja Kessler; Yungki Park; Marc Sudman; Susan D Thompson; James N Jarvis
Journal:  PLoS One       Date:  2020-07-30       Impact factor: 3.240

4.  Production of Proinflammatory Cytokines by Monocytes in Liver-Transplanted Recipients with De Novo Autoimmune Hepatitis Is Enhanced and Induces TH1-like Regulatory T Cells.

Authors:  Adam S Arterbery; Awo Osafo-Addo; Yaron Avitzur; Maria Ciarleglio; Yanhong Deng; Steven J Lobritto; Mercedes Martinez; David A Hafler; Markus Kleinewietfeld; Udeme D Ekong
Journal:  J Immunol       Date:  2016-04-18       Impact factor: 5.422

5.  Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis.

Authors:  Juliana M F Silva; Fani Ladomenou; Ben Carpenter; Sharat Chandra; Petr Sedlacek; Renata Formankova; Vicky Grandage; Mark Friswell; Andrew J Cant; Zohreh Nademi; Mary A Slatter; Andrew R Gennery; Sophie Hambleton; Terence J Flood; Giovanna Lucchini; Robert Chiesa; Kanchan Rao; Persis J Amrolia; Paul Brogan; Lucy R Wedderburn; Julie M Glanville; Rachael Hough; Rebecca Marsh; Mario Abinun; Paul Veys
Journal:  Blood Adv       Date:  2018-04-10

Review 6.  The environment of regulatory T cell biology: cytokines, metabolites, and the microbiome.

Authors:  Romy E Hoeppli; Dan Wu; Laura Cook; Megan K Levings
Journal:  Front Immunol       Date:  2015-02-18       Impact factor: 7.561

Review 7.  IL-17A-Producing Foxp3+ Regulatory T Cells and Human Diseases.

Authors:  Min Kyung Jung; Jeong-Eun Kwak; Eui-Cheol Shin
Journal:  Immune Netw       Date:  2017-10-16       Impact factor: 6.303

Review 8.  Targeting Tregs in Juvenile Idiopathic Arthritis and Juvenile Dermatomyositis-Insights From Other Diseases.

Authors:  Romy E Hoeppli; Anne M Pesenacker
Journal:  Front Immunol       Date:  2019-01-25       Impact factor: 7.561

9.  TCR repertoire sequencing identifies synovial Treg cell clonotypes in the bloodstream during active inflammation in human arthritis.

Authors:  Maura Rossetti; Roberto Spreafico; Alessandro Consolaro; Jing Yao Leong; Camillus Chua; Margherita Massa; Suzan Saidin; Silvia Magni-Manzoni; Thaschawee Arkachaisri; Carol A Wallace; Marco Gattorno; Alberto Martini; Daniel J Lovell; Salvatore Albani
Journal:  Ann Rheum Dis       Date:  2016-06-16       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.